Condition: Unresectable Hepatocellular Carcinoma (HCC) · Liver Metastases From Colorectal Cancer (mCRC) · Sponsor: Sirtex Medical
This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres
This description comes directly from the study's public registry record.
Janet Bell · 781-721-3840 · jbell@sirtex.com
Always discuss trial participation with your own doctor first.
| Hôpital Beaujon | Clichy, Cedex, France | Recruiting |
| Hopital Henri Mondor | Créteil, Paris, France | Not Yet Recruiting |
| Hospices Civils de Lyon HCL Centre Hospitalier Lyon-Sud | Pierre-Bénite, Rhône, France | Recruiting |
| Hospital Universitario Puerta de Hierro - Majadahonda | Majadahonda, Madrid, Spain | Not Yet Recruiting |
| Hospital General Universitario Gregorio Marañon | Madrid, Spain | Not Yet Recruiting |
| Hospital Clinico Universitario de Valencia | Valencia, Spain | Not Yet Recruiting |
| The Christie Hospital | Manchester, Lancashire, United Kingdom | Not Yet Recruiting |
| Kings College Hospital | London, United Kingdom | Not Yet Recruiting |
| Hammersmith Hospital | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05967143